PA & NP Medical Guidance | Clinical Diagnosis & Treatment
Physician assistants and nurse practitioners use Clinical Advisor for updated medical guidance to diagnose and treat common medical conditions in daily practice.
GINA 2024 Asthma Update: Revised Recommendations on …
Jul 11, 2024 · The GINA 2024 asthma update includes key changes on a number of topics, including: diagnosing asthma; cough variant asthma; assessing asthma control; goal of asthma treatment; asthma remission ...
Clinical Advisor CME/CE Courses
Program Description. Each year, respiratory syncytial virus (RSV) leads to over 2 million outpatient visits, up to 80,000 hospitalizations, and as many as 300 deaths among children younger than age 5.
Clinical Tools - Clinical Advisor
Clinical Tools. Our drug database contains more than 4000 concise product monographs (OTC & Rx) that can be easily searched by brand name, generic name, and disease state. Each monograph includes ...
The Pros and Cons of Medical Cannabis: Current Evidence
Nov 11, 2021 · Cannabis is one of the most commonly used drugs in the United States. More than 48.2 million people in the US aged 12 years and older (17.5%) have used cannabis in the last year. 1 Although ...
News Archive - Clinical Advisor
Oct 30, 2024 · COVID-19 2024–2025 Vaccines, for Everyone 6 Months and Older, Target New Strains. The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the ...
Update on Asthma Management: the 2022 GINA Report - Clinical …
Feb 23, 2023 · Asthma is a common airway disease in the United States with 8.4% of adults or 21 million persons affected. 1 Of this population, approximately 60% have inadequately controlled disease. 2 Asthma is ...
Shingles: A Complete Guide for Clinicians - Clinical Advisor
Jan 12, 2017 · Varicella, commonly known as chickenpox, manifests as the primary infection with VZV, which is a member of the family of herpesviruses. VZV then remains dormant within the sensory neurons ...
News and Features - Clinical Advisor
Congenital Heart Disease Trends Among Children in Colorado. Obeldesivir for COVID-19 Is Safe, Reduces Time to Symptom Relief in High-Risk Patients. Adult Hypertension Prevalence 47.7% From August ...
Topical NSAIDs as First-Line Treatment for Mild to Moderate ...
Apr 22, 2022 · Topical NSAIDs are recommended as first-line therapies for acute pain from musculoskeletal injuries (not including low-back pain) in clinical guidelines and are associated with a safety profile ...